Møller-Bisgaard, S, Ejbjerg, B J, Eshed, I, Hørslev-Petersen, K, Hetland, M L, Jurik, A G, Thomsen, H, Torfing, T, Stengaard-Pedersen, K, Junker, P, Krogh, N S, Lottenburger, T, Ellingsen, T, Andersen, L S, Skjødt, H, Svendsen, A J, Tarp, U, Hansen, I T, Pødenphant, J, Pedersen, J K, Lindegaard, H, Hanson, L G, Vestergaard, A, Glinatsi, D & Østergaard, M 2017, ' Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis : results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA) ', Scandinavian Journal of Rheumatology, vol. 46, no. 5, pp. 335-345 . https://doi.org/10.1080/03009742.2016.1209550 Møller-Bisgaard, S, Ejbjerg, B J, Eshed, I, Hørslev-Petersen, K, Hetland, M L, Jurik, A G, Thomsen, H, Torfing, T, Stengaard-Pedersen, K, Junker, P, Krogh, N S, Lottenburger, T, Ellingsen, T, Andersen, L S, Skjødt, H, Svendsen, A J, Tarp, U, Hansen, I T, Pødenphant, J, Pedersen, J K, Lindegaard, H, Hanson, L G, Vestergaard, A, Glinatsi, M & Østergaard, M 2017, ' Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis : results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA) ', Scandinavian Journal of Rheumatology, vol. 46, no. 5, pp. 335-345 . https://doi.org/10.1080/03009742.2016.1209550